Roche Holdings Inc.
Россия
  • Россия
  • Украина

Roche Holdings Inc.

Contact Details

340 Kingsland St, Nutley, New Jersey, USA 07110-1150
(973) 235-5000

340 Kingsland St, Nutley, New Jersey, USA 07110-1150

Contact Information

Phone
(973) 235-5000
Customer Service Phone(888) 825-5249
Website 1http://www.rocheusa.com
FacebookFacebook
LinkedInLinkedIn
BlogBlog
Twitter@Roche

Corporate Data

Industries

  • Pharmaceutical Preparation Manufacturing
  • Medicinal and Botanical Manufacturing
  • All Other Basic Organic Chemical Manufacturing

SIC Industries

  • Pharmaceutical Preparations
  • Medicinal Chemicals
  • Radioactive Diagnostic Substances
  • Industrial Organic Chemicals, Nec

Company Size

Sales Volume$1.35 billion
Employees8,700

Ownership

Year Founded1987

Corporate Venture Capital Investments

Companies Abbott Laboratories Has Invested In

CompanyCurrent StageIndustryEarliest InvestmentDate
Lumos Pharma Inc.EarlyPharmaceuticalSeries B ($34,000,000)04/06/16
Flatiron Health Inc.ExpansionInternetSeries C ($175,000,000)01/06/16
Atterocor Inc.ExpansionPharmaceuticalSeries B ($62,000,000)01/04/16
Corvus PharmaceuticalsExited (IPO)PharmaceuticalSeries B ($75,000,000)09/30/15
Sutrovax Inc.EarlyPharmaceuticalSeries A ($22,000,000)07/24/15
Macrolide PharmaceuticalsEarlyPharmaceuticalSeries A ($22,000,000)03/05/15
Avexis Inc.Exited (IPO)BiotechnologyVenture Equity ($10,000,000)01/10/15
Lysosomal Therapeutics Inc.EarlyBiotechnologySeed ($4,800,000)05/13/14
Biodesy Inc.EarlyBiotechnologySeries A ($15,000,000)10/18/13
Maculogix Inc.EarlyMedical Devices & InstrumentsSeries A ($3,600,000)03/11/13
Allakos Inc.EarlyBiotechnologySeries A ($32,000,000)12/18/12
Epic Sciences Inc.ExpansionElectronicsSeries B ($13,000,000)11/13/12
Foundation Medicine Inc.Exited (IPO)Medical Devices & InstrumentsSeries B ($56,000,000)09/21/12
DVS Sciences Inc.Exited (Acquired)BiotechnologySeries A ($14,600,000)07/14/11
Conatus Pharmaceuticals Inc.Exited (IPO)PharmaceuticalSeries B ($20,000,000)02/13/11
Cytomx Therapeutics Inc.Exited (IPO)BiotechnologyVenture Equity ($30,000,000)09/23/10
Aileron Therapeutics Inc.LateBiotechnologySeries D ($40,000,000)06/08/09
Alios Biopharma Inc.Exited (Acquired)PharmaceuticalSeries A ($8,400,000)02/09/09
Genoptix Inc.EarlyBiotechnologySeries B ($6,000,000)10/24/07
Nereus Pharmaceuticals Inc.ExpansionPharmaceuticalSeries D ($45,000,000)08/09/07
Don Kelly Construction Inc.Out of BusinessBiotechnologySeries B ($35,000,000)02/07/07
Xenon PharmaceuticalsExited (IPO)PharmaceuticalVenture Equity ($7,000,000)12/08/06
Ambrx Inc.ExpansionBiotechnologyVenture Equity ($28,364,000)06/30/06
Ambit Biosciences CorporationExited (IPO)BiotechnologySeries C ($31,000,000)05/12/05
Activbiotics Inc.Out of BusinessPharmaceuticalSeries B ($26,400,000)08/04/03
Minoryx TherapeuticsPrivate & IndependentPharmaceutical